Subsequent Events	9 Months Ended
Sep. 30, 2026
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsOn November 1, 2026 the Company’s Board of Directors (“Board”) appointed Tony Weisman, a member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of November 2, 2026. Mr. Weisman succeeds Mark Douglas as President and Chief Executive Officer, who, following 30 days of paid leave, will terminate employment with the Company on December 3, 2026. In addition, Christopher Innes ceased serving as the Company’s Chief Operating Officer and principal operating officer and, following 30 days of paid leave, will terminate employment with the Company on December 1, 2026. Both Mark Douglas and Christopher Innes are eligible to receive the severance payments and benefits under their respective employment agreements with the Company. In addition, Christopher Innes will have up to 6 months to exercise his vested stock options, which will be considered a modification under ASC 718. Both Mark Douglas and Christopher Innes have unvested performance options which are accounted for as market-based awards under ASC 718. Any unvested portion of these awards shall remain outstanding and eligible to vest for twelve months following their respective termination dates. In order to receive these severance benefits, Mark Douglas and Christopher Innes must timely provide a release of claims against the Company. The Company is currently evaluating the impact of the executive terminations on its consolidated financial statements, including its effect on stock-based compensation expense.

Subsequent Events

9 Months Ended

Sep. 30, 2026

Subsequent EventsOn November 1, 2026 the Company’s Board of Directors (“Board”) appointed Tony Weisman, a member of the Board, to serve as the Company’s President and Chief Executive Officer, effective as of November 2, 2026. Mr. Weisman succeeds Mark Douglas as President and Chief Executive Officer, who, following 30 days of paid leave, will terminate employment with the Company on December 3, 2026. In addition, Christopher Innes ceased serving as the Company’s Chief Operating Officer and principal operating officer and, following 30 days of paid leave, will terminate employment with the Company on December 1, 2026. Both Mark Douglas and Christopher Innes are eligible to receive the severance payments and benefits under their respective employment agreements with the Company. In addition, Christopher Innes will have up to 6 months to exercise his vested stock options, which will be considered a modification under ASC 718. Both Mark Douglas and Christopher Innes have unvested performance options which are accounted for as market-based awards under ASC 718. Any unvested portion of these awards shall remain outstanding and eligible to vest for twelve months following their respective termination dates. In order to receive these severance benefits, Mark Douglas and Christopher Innes must timely provide a release of claims against the Company. The Company is currently evaluating the impact of the executive terminations on its consolidated financial statements, including its effect on stock-based compensation expense.